UK MHRA's communication strategy aims to improve engagement with public
This article was originally published in SRA
Executive Summary
The UK Medicines and Healthcare products Regulatory Agency's third communication strategy1, covering 2010-15, identifies the public as the MHRA's primary stakeholder, with industry, agency staff and healthcare professionals described as priority "enabler" stakeholders that will assist in delivering the agency's service to the public.